Less Injections, Same Weight‑Loss Success
Can You Skip Some GLP‑1 Shots and Still Keep the Weight Off?
A recent study followed 34 people who had already lost weight on GLP‑1 medications (like Wegovy and Ozempic). The researchers let them extend the interval between injections, then tracked their progress over 36 weeks.
| Dosing schedule | Participants |
|---|---|
| Every other week | 17 |
| Every 10‑14 days | 6 |
| Beyond two weeks (some up to six) | 7 |
Key Findings
Most participants stayed lean.
Blood pressure and blood‑sugar levels remained lower than before.Only four people gained weight, and they returned to weekly dosing.
The group that tried a two‑week gap—like the 65‑year‑old who lost 20 pounds on weekly Wegovy—found no difference and kept the slower schedule, adding regular elliptical workouts and cutting out snacks between meals.
About 12% of those who spaced injections later returned to weekly shots after regaining weight.
Limitations
- Small sample size, mostly white and privately insured.
- No control group; data derived from existing records.
- Results may not generalize to all patients.
Implications
The study suggests that chronic GLP‑1 therapy doesn’t necessarily require a weekly injection for everyone. For motivated patients, personalized dosing schedules could reduce cost and insurance barriers while maintaining weight‑loss benefits.
